Skip to main content
. 2016 May 23;101(8):3061–3069. doi: 10.1210/jc.2016-1545

Figure 3.

Figure 3.

One male subject with reversal and relapse of hypogonadotropic hypogonadism at initial clinical presentation (A) and during the kisspeptin study (B). Dashed lines indicate iv boluses. T, testosterone; TV, testicular volume; BL, bilateral.